MG冰球突破官网
Contact Us
EN
|
简
|
繁
|
About Us
Company Profile
Enterprise Style
Leadership
Awards & Certificates
Milestones
Collaborations
Media
Press Release
Publication News
Platforms
Novel Adjuvant
Protein Engineering
Immunological Evaluation
Pipeline
Pipeline
HPV Vaccine
Shingles
COVID-19 Vaccine
Manufacturing
HPV Vaccine Manufacturing Facility
Innovation Vaccine (CHO cell) Manufacturing Facility
Investors
Announcements & Circulars
Prospectus
Corporate Governance
Share Graph
Financial Calendar
Presentation & Webcast
Financial Reports
Analyst Coverage
Email Alert
Careers
Job Opportunities
Contact Us
About Us
Company Profile
Enterprise Style
Leadership
Awards & Certificates
Milestones
Collaborations
Media
Press Release
Publication News
Platforms
Novel Adjuvant
Protein Engineering
Immunological Evaluation
Pipeline
Pipeline
HPV Vaccine
Shingles
COVID-19 Vaccine
Manufacturing
HPV Vaccine Manufacturing Facility
Innovation Vaccine (CHO cell) Manufacturing Facility
Investors
Announcements & Circulars
Prospectus
Corporate Governance
Share Graph
Financial Calendar
Presentation & Webcast
Financial Reports
Analyst Coverage
Email Alert
Careers
Job Opportunities
Contact Us
Financial Reports
Financial
Reports
2025 Annual Report
2026/04/29
2025 Interim Report
2025/09/25
2024 Annual Report
2025/04/22
2024 Interim Report
2024/09/26
2023 Annual Report
2024/04/16
2023 Interim Report
2023/09/26
2022 Annual Report
2023/04/20
2022 Interim Report
2022/09/26
2021 Annual Report
2022/04/27
best365官网体育投注
